source
- Temple Health’s Fox Chase Cancer Center and Labcorp Collaborate to Test Ultra-Sensitive Blood-Based Assay for Early-Stage Lung Cancer Recurrence RiskA Fox Chase Cancer Center study will evaluate a tumor-informed, whole-genome sequencing–based test to assess recurrence risk in early-stage NSCLC.onclive · 2mo ago↗ source
- FDA Grants Breakthrough Therapy Designation to Emi-Le for Adenoid Cystic CarcinomaEmi-Le received breakthrough therapy designation from the FDA for the treatment of patients with locally advanced, recurrent or metastatic ACC.onclive · 2mo ago↗ source
- [177Lu]Lu-D-Dan-Phe-PSMA Demonstrates Manageable Safety and Early Efficacy mCRPC[177Lu]Lu-D-Dan-Phe-PSMA showed early signals of safety and activity in mCRPC.